Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32901569.
- Also identified by DOI 10.2214/AJR.20.22790.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> The purpose of this article is to summarize the protocol, interpretation, and diagnostic performance of nuclear medicine and molecular imaging in imaging two distinctive, underdiagnosed cardiomyopathies: cardiac amyloidosis and cardiac sarcoidosis. <b>CONCLUSION.</b> Emerging new radiotracers and advanced molecular imaging modalities enable us to noninvasively characterize certain types of cardiomyopathies, including cardiac amyloidosis and cardiac sarcoidosis, with great confidence. We expect to improve recognition and promote the application of such advanced techniques in the imaging and management of these potentially lethal cardiomyopathies.
Medical subject headings
- Amyloidosis
- Cardiomyopathies
- Sarcoidosis